The Genetics of Pulmonary Fibrosis Study

This study is looking for people aged 18 or older who have a family member diagnosed with Idiopathic Pulmonary Fibrosis (IPF), a serious lung disease. The goal is to understand how genes and environmental factors might lead to pulmonary fibrosis. You would participate by having a blood draw and completing a questionnaire. The researchers hope to identify specific genetic areas that are linked to the development of this condition. The study is currently enrolling up to 1000 participants, but its current status is unclear.

Study design
This is an observational study, meaning researchers will observe and collect information without giving any specific treatments. It plans to enroll up to 1000 participants.
What's involved
You would have a blood draw and complete a questionnaire.
Compensation
Not stated in the trial record.
Follow-up
The primary goal is measured at baseline, meaning at the start of your participation.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT03478553

The Genetics of Pulmonary Fibrosis

Recruiting
Not specifiedAges 18+Observational
University of Colorado, Denver
~1,000 participants
Updated 2025-03-25 on ClinicalTrials.gov
What's tested:Blood drawQuestionnaire

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Identify and explore genetic loci and related environmental exposures in individuals with familial pulmonary fibrosis and their relatives.
Measured over Baseline
Idiopathic Pulmonary Fibrosis (IPF)

NCT03478553

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • University of Colorado Anschutz Medical Campus

    Aurora, Coloradostudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

  • David A Schwartz, MD · PRINCIPAL_INVESTIGATOR · University of Colorado, Denver

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Age at least 18 years old
Family member diagnosed with IPF
  • Identify and explore genetic loci and related environmental exposures in individuals with familial pulmonary fibrosis and their relatives.Baseline

    The investigators aim is to identify and explore genetic loci that affect development of pulmonary fibrosis and also explore related environmental exposures. Idiopathic pulmonary fibrosis (IPF) is one of the interstitial lung diseases under the broader umbrella of idiopathic interstitial pneumonias (IIP). The investigators hypothesize that inherited genetic factors are associated with pulmonary fibrosis.